Table 3.

Cardiovascular disease events and adverse event during 1-year observation period

Events	Control, n=120	BIA, n=120	P Value
Cardiovascular disease events, n=31
Congestive heart failure, n=22	13 (10%)	9 (8%)	0.42
Myocardial infarction, n=1	0	1 (1%)	0.54
Angina pectoris, n=2	1 (1%)	1 (1%)	0.94
Cerebral infarction/hemorrhage, n=4	2 (2%)	2 (2%)	0.96
Peripheral vascular disease, n=2	1 (1%)	1 (1%)	0.95
Adverse event
Hypotension, n=0	0	0	—

Log-rank test was used to compare the events between two groups. BIA, bioelectrical impedance analysis; —, not applicable.